Your browser doesn't support javascript.
loading
Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates.
Ong, Eugenia Z; Budigi, Yadunanda; Tan, Hwee Cheng; Robinson, Luke N; Rowley, Kirk J; Winnett, Alexander; Hobbie, Sven; Shriver, Zachary; Babcock, Gregory J; Ooi, Eng Eong.
Afiliação
  • Ong EZ; Experimental Therapeutics Centre, Agency for Science, Technology and Research, Singapore; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Budigi Y; Visterra Singapore International Pte Ltd, Singapore.
  • Tan HC; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Robinson LN; Visterra Inc, Cambridge, MA, USA.
  • Rowley KJ; Visterra Inc, Cambridge, MA, USA.
  • Winnett A; Visterra Inc, Cambridge, MA, USA.
  • Hobbie S; Visterra Singapore International Pte Ltd, Singapore.
  • Shriver Z; Visterra Inc, Cambridge, MA, USA.
  • Babcock GJ; Visterra Inc, Cambridge, MA, USA.
  • Ooi EE; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore; Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Singapore-MIT Alliance in Research and Technology, Infectious Diseases Interdisciplinary Research Group, Singapore. E
Antiviral Res ; 144: 44-47, 2017 08.
Article em En | MEDLINE | ID: mdl-28529000

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Antivirais / Dengue / Vírus da Dengue / Fatores Imunológicos / Imunoterapia / Anticorpos Antivirais Limite: Animals Idioma: En Revista: Antiviral Res Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Antivirais / Dengue / Vírus da Dengue / Fatores Imunológicos / Imunoterapia / Anticorpos Antivirais Limite: Animals Idioma: En Revista: Antiviral Res Ano de publicação: 2017 Tipo de documento: Article